Previous 10 | Next 10 |
5 Penny Stocks To Watch This Week When it comes to penny stocks , the right mix of risk and reward needs to be taken into consideration. All too often, novice traders and investors treat these cheap stocks like lottery tickets. In actuality, they are investments like any other. One of the big...
5 Penny Stocks To Trade [or Avoid] Before The Weekend Investing in penny stocks has often proven to be a quick way of making substantial returns from a small account. Over the years, many investors have made fortunes through these stocks. Hence, there’s always a focus on finding the n...
Three-arm, three-month study will compare Viveve's cryogen-cooled monopolar radiofrequency (CMRF) treatment and cryogen-only sham to inert sham treatment ENGLEWOOD, CO / ACCESSWIRE / January 14, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women...
Cellect Biotechnology (NASDAQ: APOP ) +141% on new patents . More news on: Cellect Biotechnology Ltd., Apellis Pharmaceuticals, Inc., Advaxis, Inc., Stocks on the move, Read more ...
Losers: Leap Therapeutics (NASDAQ: LPTX ) +49% . More news on: Leap Therapeutics, Inc., Yuma Energy, Inc., Inpixon, Stocks on the move, Read more ...
Gainers: Inpixon (NASDAQ: INPX ) +125% . More news on: Inpixon, Synthesis Energy Systems, Inc., Trillium Therapeutics Inc., Stocks on the move, Read more ...
Are These Penny Stocks To Buy Or Should You Avoid Them At All Costs? When it comes to penny stocks to buy , one of the most important things to keep in mind is that it is possible to make a lot of money in short timeframes. Therefore, there is a lot of interest in these cheap stocks. Investor...
ENGLEWOOD, CO / ACCESSWIRE / December 31, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, announced today that it has been notified by Nasdaq that Viveve has regained compliance with the Nasdaq Capital Market continued listing req...
The Canadian Ministry of Health has signed off on a three-arm, three-month, 36-subject feasibility study evaluating Viveve Medical's ( VIVE +1.2% ) cryogen-cooled monopolar radiofrequency (CMRF) to improve stress urinary incontinence (SUI) in women. More news on: Viveve Medical, Inc., ...
Three-arm, three-month study will compare Viveve's cryogen-cooled monopolar radiofrequency (CMRF) treatment and cryogen-only sham to an inert sham treatment ENGLEWOOD, CO / ACCESSWIRE / December 18, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on wome...
News, Short Squeeze, Breakout and More Instantly...
Novonix Limited (NVNXF) is expected to report for quarter end 2023-12-31 MedAvail Holdings Inc. (MDVL) is expected to report for Q3 2023 Nobility Homes, Inc. (NOBH) is expected to report for quarter end 2023-10-31 Walgreens Boots Alliance Inc. (WBA) is expected to report $0.66 for Q1 ...
Disco Corporation ADR (DSCSY) is expected to report for Q2 2024 Sonic Foundry Inc. (SOFO) is expected to report for quarter end 2023-09-30 Sono Group N.V. (SEVCQ) is expected to report for quarter end 2023-09-30 Minim Inc (MINM) is expected to report for Q3 2023 Enel Spa ADR (ENLA...
Enel Spa ADR (ENLAY) is expected to report for Q3 2023 LEG Immobilien SE Registered Shares (LEGIF) is expected to report for Q3 2023 G. Willi-Food International Ltd. (WILC) is expected to report for Q3 2023 Worthington Steel Inc. (WS) is expected to report $0.15 for Q2 2024 Sonic ...